Alterola Biotech Inc. Registration Statement Declared Effective

Author's Avatar
Nov 12, 2021

BIRKENHEAD, UK / ACCESSWIRE / November 12, 2021 / Alterola Biotech Inc. ("Alterola Biotech" or the "Company") (OTC PINK:ABTI)a clinical-stage biotechnology company focused on developing cannabinoid therapies for the treatment of diseases, having filed its Registration Statement on Form S-1 with the Securities and Exchange Commission on the 19th of October 2021, has been informed that the Registration Statement has been declared effective.